Product Overview
[Drug Name]
Generic Name: Compound Pancreatin Tablets
Trade Name: Weixian
English Name: Compound Pancreatin Tablets
Chinese Pinyin: Fufang Yimei Pian
[Ingredients]
This product is a compound preparation. Each tablet contains 50mg of pancreatin, 50mg of pig bile paste, and appropriate amounts of excipients.
[Properties]
This product is enteric-coated tablet. After removing the enteric coating, it appears light brown.
[Indications]
For the treatment of indigestion and loss of appetite.
[Dosage and Administration]
Oral administration. Take 2-4 tablets three times daily before meals.
[Adverse Reactions]
Occasionally, allergic reactions such as sneezing, tearing, rash, and asthma may occur. It may cause pain around the mouth and anus.
[Contraindications]
This product is contraindicated in patients with allergies.
[Precautions]
1. This product is easily destroyed in acidic conditions and should not be taken with acidic medications.
2. Do not crush the tablets during oral administration to prevent oral ulcers.
3. Do not use if the drug's properties have changed.
[Use in Special Populations]
Precautions for children: Not yet available.
Precautions for pregnancy and lactation: Not yet available.
Precautions for the elderly: Not yet available.
[Drug Interactions]
1. This product is most effective in neutral or slightly alkaline environments.
2. Its efficacy is reduced when taken with acidic medications.
[Pharmacological Actions]
The pancreatic enzymes in this product are a mixture of enzymes, primarily trypsin, pancreatic amylase, and pancreatic lipase. They are most active in neutral or slightly alkaline conditions. In intestinal fluid, they convert starch to sugar, protein to peptone, and fat to glycerol and fatty acids. Sodium bicarbonate can enhance pancreatic enzyme activity.
[Storage]
Store in a sealed container.
[Specifications]
Pancreatic enzymes 50mg, pig bile paste 50mg
[Packaging]
24 tablets/box
[Validity Period]
24 months
[Approval Number]
National Medicine Standard H61022561
[Manufacturer]
Shaanxi Bosen Biopharmaceutical Group Co., Ltd.
